Where is TNMS located?

TNMS is headquartered in Metairie, United States.

Is TNMS a funded company?

TNMS is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Oct 15, 2017.

When was the latest funding round of TNMS?

TNMS's latest funding was a $***** Seed round on Oct 15, 2017, with participation from 0 investor. Its primary sector is Disease Self Management. In United States, the Disease Self Management sector has seen $811M in funding in 2026 to date.

Where does TNMS rank among its competitors?

TNMS ranks 10th amongst 18 active competitors, of which 3 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Neuros Medical, which secured $56M in Jul, 2025.

Who are the top competitors of TNMS?

TNMS's top competitors include Neuros Medical, Neurosteer and Ryseup. Among them, Neuros Medical secured the most recent funding round in July, 2025.

TNMS - 2026 Company Profile, Funding & Competitors

Company Details

Developer of non-pharmaceutical neuromodulation devices for pain and recovery. These medical devices use percutaneous electrical nerve stimulation to target nerve pathways and trigger the body to release natural pain relievers. The technology is applied to manage chronic and acute pain, support post-operative healing, and assist in opioid withdrawal processes. By avoiding medication, these wearable tools aim to reduce pain sensitivity, lower inflammation, and improve patient mobility. The devices are positioned behind the ear to provide continuous stimulation for patients seeking drug-free alternatives to traditional pain management.

Website: tnmsmedtech.com
Phone Number: +1 **********

Key Metrics

Location

Metairie, United States

Stage

Seed

Total Funding

$1.71M in 1 round

Latest Funding Round

Seed, Oct 15, 2017, $*****

Ranked

10^th among 18 active competitors

Similar Companies

Neuros Medical & 19 more

View TNMS's full profile

TNMS has raised a total funding of $1.71M over 1 round.

Here is the list of recent funding rounds of TNMS:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 15, 2017	2144203	Seed	2765427	1527290	7859424	2386322

Access funding benchmarks and valuations. Sign up today!

View details of TNMS's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TNMS include Neuros Medical, Neurosteer and Ryseup. Here is the list of Top 10 competitors of TNMS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuros Medical 2008, Cleveland (United States), Series D	Neurostimulation therapy for chronic neuropathic pain	$145M	Glengary, Sectoral & 25 others	59/100
2nd	Neurosteer 2015, Herzliya (Israel), Funding Raised	Developer of a wearable band and a cloud platform for monitoring brain signals	-	EIC Fund, Europa	32/100
3rd	Ryseup 2016, West Hollywood (United States), Unfunded	Provider of pulsed electromagnetic field (PEMF) wellness devices and programs	-	-	28/100
4th	NuroKor 2018, London (United Kingdom), Seed	Provider of wearable technology for pain management and recovery optimization	$6.16M	-	26/100
5th	Pain Management Technologies 2021, Delhi (India), Unfunded	Developer of electrotherapy device for pain management	-	-	24/100
6th	Hinge Health 2014, San Francisco (United States), Unfunded	Provider of virtual physical therapy and musculoskeletal pain management services	-	-	23/100
7th	MicuFlow 2023, Dinklage (Germany), Funding Raised	Platform offering frequency specific microcurrent therapy	-	OHA	23/100
8th	iPulser 2018, Agoura Hills (United States), Unfunded	Provider of a non-invasive device to treat chronic pain	-	-	21/100
9th	Strohl Medical Technologies 2009, Norwell (United States), Deadpooled	Portable electrodiagnostic device for stroke detection	-	Springboard Enterprises, MassChallenge & 3 others	21/100
10th	TNMS Metairie (United States), Seed	Developer of non-pharmaceutical neuromodulation devices for pain and recovery	$1.71M	-	20/100